HERO IMAGE What Is Ellanse

What is ELLANSÉ?

The dual-action treatment for firmer, more youthful-looking skin. Click to see more

Model is not an actual patient.

ELLANSÉ is a dual-action dermal filler that does
so much more than just correcting lines and folds.
It works fast to give visible results – then it gets to
work deep under the skin to tackle the real causes
of facial ageing.

How ELLANSÉ is different

Polycaprolactone. The name you won’t want to forget.

This absorbable and biodegradable material, is the basis of the ELLANSÉ filler, beloved by celebrities for achieving the most subtle and long-lasting results.
07
Model is not an actual patient.

The purpose of fillers

From the age of 25, the face loses around 1% of its volume per year. This is because the collagen in the skin breaks down, making the skin thinner and drier and causing wrinkles. Hence, the primary purpose of filler products is to compensate for these losses. But what are the choices?
08
Model is not an actual patient.

A fast and noticeable improvement in skin quality.

Hyaluronic acid-based products simply improve volume in the short-term. However, collagen biostimulating products not only deliver rapid results, but also improve the quality of the skin in the medium and long term, so their effect is sustained.
Sinclair Ellanse Shot 04 070
Model is not an actual patient.

Choice is the deciding factor

We can employ temporary products which remain in the skin for between 3-8 months; we can use collagens or hyaluronic acids (which are simply fillers - the injected volume is the only effective change); or we can apply durable products, which have lasting effect from 18 months to 3 years,* such as ELLANSÉ, a Polycaprolactone-based filler (with a secondary action that stimulates the natural production of collagen for more enduring results).
03
Model is not an actual patient.

Ideal for deep volumes and rejuvenation

Ellansé is made of polycaprolactone that belongs to the class of biodegradable aliphatic (open chain) polyester designed for medicine and perfect to treat wrinkles in the midface area and around the mouth when used in a dermal filler. Ellansé is ideal for deep volume, and also as a simple collagen stimulator to rejuvenate the skin without adding volume.
02
Model is not an actual patient.

Instant results from the first session

An advantage of ELLANSÉ is that a single* session is enough to correct and rejuvenate (depending on the lack of tissue and ageing of the skin).

ELLANSÉ can be applied with an anesthetic cream or local anesthetic injection to ensure totally pain-free administration.

Continue the conversation
*Individual results may vary, multiple sessions may be required depending on the individual. Model is not an actual patient.
Model Image 20

How ELLANSÉ compares to other available treatments

Model is not an actual patient.

Click to Compare
brown-haired ELLANSÉ model on sofa

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

Important Safety Considerations:

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules etc.), pain (which may be temporary or persistent in nature), transient haematoma or bruising.

Other potential adverse events include

- Injection related reactions, include itching, discoloration or tenderness may occur at the site of the injection. These usually resolve spontaneously within several days after the injection.

- As with any implant material possible adverse reactions that may occur include, but are not limited to the following: hypersensitivity, allergic reactions, inflammation, infection, fistula formation, haematoma, seroma, extrusion, induration formation, inadequate healing, skin discoloration, oedema, contusions/bruises, ecchymosis, inadequate or excessive augmentation, loss of correction, interference with local circulation if injected into a blood vessel resulting in vessel laceration, occlusion, embolism, infarction, and abscess at implant site which may result in induration and/or scar formation.

- Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage, leading to stroke, skin necrosis, damage to underlying facial structures, nausea and vomiting, lack of ocular movement, significant skin changes, ptosis, exotropia and neurological complications.

- Adverse events, other than mentioned above, could occur as can be with any medical intervention.

All (potential) adverse side effects and incidents should be reported immediately to the Sinclair Pharma Corporate Safety Group: quality@sinclairpharma.com